Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Allergan Information Consulting (Shanghai) Co., Ltd. is the primary commercial and consulting subsidiary for Allergan's operations in China, now operating as part of AbbVie following the 2020 acquisition. The company specializes in the marketing, regulatory navigation, and professional support of a market-leading portfolio in medical aesthetics, ophthalmology, and neuroscience. Its most prominent products include the botulinum toxin Botox, the Juvéderm line of dermal fillers, and various specialty treatments for eye care and central nervous system disorders. Based in Shanghai, the entity serves as a strategic hub for expanding AbbVie's footprint in the rapidly growing Chinese healthcare and aesthetics market. It provides essential technical services and market research to support the clinical adoption of innovative specialty pharmaceuticals and medical devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Allergan Information Consulting.